Drug: Zelnorm
2006 sales: $561 million
Manufacturer: Novartis
Safety concern: Recall; heart risks
Related Articles:
> FDA allows limited Zelnorm use. Report [1]
> Novartis shares slide after Zelnorm gets yanked. Report [2]
> EMEA committee rejects Novartis' Zelnorm. Report [3]
Links:
[1] http://www.fiercebiotech.com/story/spotlight-fda-allows-limited-zelnorm-use/2007-07-27
[2] http://www.fiercebiotech.com/story/novartis-shares-slide-after-zelnorm-gets-yanked/2007-04-02
[3] http://www.fiercebiotech.com/story/emea-committee-rejects-novartis-zelnorm/2005-12-15